Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
mitral regurgitation
MedTech
TMVR maker 4C Medical scores $35M and a new CEO to boot
In contrast to other TMVR devicemakers like Abbott and Medtronic, 4C Medical Technologies is following its heart down a slightly different path.
Andrea Park
Mar 31, 2022 4:10pm
InnovHeart nabs J&J, Haemonetics alum as CEO
Mar 30, 2022 11:28am
InnovHeart lands $55M to take TMVR system to clinical trials
Jan 27, 2022 11:50am
Abbott nets EU approval for next-gen MitraClip
Sep 21, 2020 9:00am
Abbott nets CE mark for transcatheter mitral valve replacement
Jan 30, 2020 12:46pm
LivaNova to drop TMVR plans in global heart valve restructuring
Nov 21, 2019 10:56am
